Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00788528 · ClinicalTrials.gov registry record · Phase 2

Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects

A Phase 2 study of Obesity, sponsored by Shionogi.

Completed
Registry status
Phase 2
Development phase
766
Enrollment target
20
Study locations

NCT00788528 is a Phase 2 study of Obesity that has completed, run by Shionogi. The registered enrollment target is 766 participants, roughly in line with the 818-participant average among 1,053 other Obesity trials with a reported enrollment target. The trial reports 20 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00788528, a Phase 2 study of Obesity, has completed, sponsored by Shionogi.

COMPLETED
Registry status
Phase 2
Development phase
766 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this open-label extension study is to evaluate the safety and efficacy of velneperit (S-2367) in obese subjects.

Conditions Studied

Obesity

Interventions

  • DRUG S-2367 (velneperit)

Study Locations (20)

Florida

  • - Coral Gables
  • - Jacksonville
  • - Jacksonville
  • - Ocala
  • - Orlando
  • - Stuart

California

  • - Carmichael
  • - Fountain Valley
  • - Sacramento
  • - San Diego
  • - San Francisco

Alabama

  • - Birmingham
  • - Huntsville
  • - Mobile

Arizona

  • - Phoenix
  • - Tucson

Connecticut

  • - Stamford
  • - Waterbury

Arkansas

  • - Hot Springs

Georgia

  • - Atlanta

Trial Details

FieldValue
Enrollment Target 766 participants
Start Date 2008-08
Est. Completion 2010-03
Phase Phase 2

Sponsor

Shionogi

54 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00788528

The ClinicalTrials.gov registry entry for NCT00788528 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 766 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 818-participant average among 1,053 other Obesity trials with a reported enrollment target. The listed sponsor is Shionogi, which has 54 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which S-2367 (velneperit) is the first listed.

NCT00788528 reports 20 study locations spanning 7 distinct geographic areas - top geographies include Florida, California, Alabama.

Frequently Asked Questions

What is clinical trial NCT00788528 about?

NCT00788528 is a clinical study titled "Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects". The purpose of this open-label extension study is to evaluate the safety and efficacy of velneperit (S-2367) in obese subjects.

What is the current status of trial NCT00788528?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 766 participants. The study started on 2008-08. Estimated completion is 2010-03.

What conditions does trial NCT00788528 study?

This clinical trial studies the following conditions: Obesity.

What interventions are being tested in trial NCT00788528?

The interventions under investigation include: S-2367 (velneperit) (DRUG).

Who is sponsoring clinical trial NCT00788528?

This trial is sponsored by Shionogi, which has 54 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00788528 being conducted?

This trial has 20 study locations across Alabama, Arizona, Arkansas, California, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Obesity

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.